norfenfluramine

(+)-Norfenfluramine, the principal hepatic metabolite of (+)-fenfluramine, acts as a selective agonist for the 5-HT2B receptor, exhibiting a potent K i of 11.2 nM. It significantly promotes the hydrolysis of inositol phosphates and heightens intracellular Ca2+ levels. This compound is valuable in the study of primary pulmonary hypertension and valvular heart disease.

Norfenfluramine hydrochloride ((±)-Norfenfluramine hydrochloride) is the primary metabolite of Fenfluramine, resulting from its N-dealkylation. It serves as a potent anorectic agent and can modulate serotonin neurotransmission. In addition, Norfenfluramine hydrochloride exhibits sedative effects following acute administration.

(+)-Norfenfluramine hydrochloride, a significant liver metabolite of (+)-fenfluramine, functions as a selective agonist for the 5-HT 2B receptor (K i: 11.2 nM), effectively stimulating inositol phosphate hydrolysis and elevating intracellular Ca2+. It is utilized in research focusing on primary pulmonary hypertension and valvular heart disease.